The shift of an intestinal "Microbiome" to a "Pathobiome" governs the course and outcome of sepsis following surgical injury

Shock

Volumn 45, Issue 5, 2016, Pages 475-482

  Krezalek, Monika A ^a   Defazio, Jennifer ^a   Zaborina, Olga ^a   Zaborin, Alexander ^a   Alverdy, John C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Intestinal microbiota; late onset sepsis; non resolving inflammation; pathoadaptive immune response; pathobiota

Indexed keywords

COMMENSAL; CRITICAL ILLNESS; DISEASE SEVERITY; HOST; HUMAN; IMMUNITY; INCIDENCE; INFECTION PREVENTION; INFLAMMATION; INTESTINE FLORA; PATHOGENESIS; REMOTE SENSING; REVIEW; SEPSIS; SURGICAL INJURY; SURGICAL PATIENT; GASTROINTESTINAL TRACT; INTENSIVE CARE UNIT; MICROBIOLOGY; MICROFLORA; PEROPERATIVE COMPLICATION; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

GASTROINTESTINAL TRACT; HUMANS; INTENSIVE CARE UNITS; INTRAOPERATIVE COMPLICATIONS; MICROBIOTA; POSTOPERATIVE COMPLICATIONS; SEPSIS;

EID: 84964211714     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000534     Document Type: Review

References (98)

1. Walkey AJ, Lagu T, Lindenauer PK. Trends in sepsis and infection sources in the United States A population-based study. Ann Am Thorac Soc. 12(2): 216-220, 2015.
2. Donnelly JP, Hohmann SF, Wang HE. Unplanned Readmissions After Hospitalization for Severe Sepsis at Academic Medical Center-Affiliated Hospitals. Crit Care Med. 43: 1916-1927, 2015.
3. Bateman BT, Schmidt U, Berman MF, Bittner EA. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample. Anesthesiology. 112(4): 917-925, 2010.
4. Tulloch LG, Chan JD, Carlbom DJ, Kelly MJ, Dellit TH, Lynch JB. Epidemiology and Microbiology of Sepsis Syndromes in a University-Affiliated Urban Teaching Hospital and Level-1 Trauma and Burn Center. J Intensive Care Med; 2015 [Epub ahead of print
5. Otto GP, Sossdorf M, Claus RA, Rodel J, Menge K, Reinhart K, Bauer M, Riedemann NC. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care. 15(4): R183, 2011.
6. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 348(2): 138-150, 2003.
7. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, Allombert C, Mougin B, Malcus C, Poitevin-Later F, et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock. 34(4): 358-363, 2010.
8. Samuelsson A, Isaksson B, Hanberger H, Olhager E. Late-onset neonatal sepsis, risk factors and interventions: an analysis of recurrent outbreaks of Serratia marcescens, 2006-2011. J Hosp Infect. 86(1): 57-63, 2014.
9. Carl MA, Ndao IM, Springman AC, Manning SD, Johnson JR, Johnston BD, Burnham CA, Weinstock ES, Weinstock GM, Wylie TN, et al. Sepsis from the gut: the enteric habitat of bacteria that cause late-onset neonatal bloodstream infections. Clin Infect Dis. 58(9): 1211-1218, 2014.
10. Struelens MJ. Detection of microbial DNAemia: does it matter for sepsis management?. Intensive Care Med. 36(2): 193-195, 2010.
11. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 15(5): 496-497, 2009.
12. Culshaw N, Glover G, Whiteley C, Rowland K, Wyncoll D, Jones A, Shankar-Hari M. Healthcare-Associated bloodstream infections in critically ill patients: descriptive cross-sectional database study evaluating concordance with clinical site isolates. Ann Intensive Care. 4: 34, 2014.
13. Sertaridou E, Papaioannou V, Kolios G, Pneumatikos I. Gut failure in critical care: old school versus new school. Ann Gastroenterol. 28(3): 309-322, 2015.
14. Stecher B, Maier L, Hardt WD. Blooming in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol. 11(4): 277-284, 2013.
15. Seal JB, Morowitz M, Zaborina O, An G, Alverdy JC. The molecular Kochs postulates and surgical infection: a view forward. Surgery. 147(6): 757-765, 2010.
16. Mekalanos JJ. Environmental signals controlling expression of virulence determinants in bacteria. J Bacteriol. 174(1): 1-7, 1992.
17. Rowley G, Spector M, Kormanec J, Roberts M. Pushing the envelope: extracytoplasmic stress responses in bacterial pathogens. Nat Rev Microbiol. 4(5): 383-394, 2006.
18. Fink D, Romanowski K, Valuckaite V, Babrowski T, Kim M, Matthews JB, Liu D, Zaborina O, Alverdy JC. Pseudomonas aeruginosa potentiates the lethal effect of intestinal ischemia-reperfusion injury: the role of in vivo virulence activation. J Trauma. 71(6): 1575-1582, 2011.
19. Babrowski T, Romanowski K, Fink D, Kim M, Gopalakrishnan V, Zaborina O, Alverdy JC. The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a discrete hypervirulent morphotype capable of causing lethal peritonitis. Surgery. 153(1): 36-43, 2013.
20. Babrowski T, Holbrook C, Moss J, Gottlieb L, Valuckaite V, Zaborin A, Poroyko V, Liu DC, Zaborina O, Alverdy JC. Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut-derived sepsis in mice during chronic morphine administration. Ann Surg. 255(2): 386-393, 2012.
21. Romanowski K, Zaborin A, Valuckaite V, Rolfes RJ, Babrowski T, Bethel C, Olivas A, Zaborina O, Alverdy JC. Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype. PLoS One. 7(1): e30119, 2012.
22. Lisboa T, Waterer G, Rello J. We should be measuring genomic bacterial load and virulence factors. Crit Care Med. 38(10 Suppl): S656-S662, 2010.
23. Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translational systems biology of inflammation. PLoS Comput Biol. 4(4): e1000014, 2008.
24. Namas R, Zamora R, Namas R, An G, Doyle J, Dick TE, Jacono FJ, Androulakis IP, Nieman GF, Chang S, et al. Sepsis: something old, something new, and a systems view. J Crit Care. 27(3): 314e1-3211e, 2012.
25. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12(9): 412-416, 2004.
26. Ackerman J. The ultimate social network. Sci Am. 306(6): 36-43, 2012.
27. Nogueira T, Rankin DJ, Touchon M, Taddei F, Brown SP, Rocha EP. Horizontal gene transfer of the secretome drives the evolution of bacterial cooperation and virulence. Curr Biol. 19(20): 1683-1691, 2009.
28. Hol FJ, Galajda P, Nagy K, Woolthuis RG, Dekker C, Keymer JE. Spatial structure facilitates cooperation in a social dilemma: empirical evidence from a bacterial community. PLoS One. 8(10): e77042, 2013.
29. Stecher B, Denzler R, Maier L, Bernet F, Sanders MJ, Pickard DJ, Barthel M, Westendorf AM, Krogfelt KA, Walker AW, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A. 109(4): 1269-1274, 2012.
30. Alverdy JC, Chang EB. The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndromewill not go away. J Leukocyte Biol. 83(3): 461-466, 2008.
31. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the motor of critical illness. Shock. 28(4): 384-393, 2007.
32. Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness. Trends Mol Med. 20(4): 214-223, 2014.
33. Wren BW. Microbial genome analysis: insights into virulence, host adaptation and evolution. Nat Rev Genet. 1(1): 30-39, 2000.
34. Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, Monack DM. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun. 76(1): 403-416, 2008.
35. Zaborin A, Smith D, Garfield K, Shakhsheer B, Kade M, Tirrell M, Tiedje J, Gilbert J, Zaborina O, Alverdy JC. Membership and behavior of ultra-lowdiversity pathogen communities present in the gut of humans during prolonged critical illness. MBio. 5(5): 1-14, 2014.
36. Hayakawa M, Asahara T, Henzan N, Murakami H, Yamamoto H, Mukai N, Minami Y, Sugano M, Kubota N, Uegaki S, et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci. 56(8): 2361-2365, 2011.
37. Shimizu K, Ogura H, Hamasaki T, Goto M, Tasaki O, Asahara T, Nomoto K, MorotomiM, Matsushima A, Kuwagata Y, et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci. 56(4): 1171-1177, 2011.
38. Zaborin A, Romanowski K, Gerdes S, Holbrook C, Lepine F, Long J, Poroyko V, Diggle SP, Wilke A, Righetti K, et al. Red death in Caenorhabditis elegans caused by Pseudomonas aeruginosa PAO1. Proc Natl Acad Sci U S A. 106(15): 6327-6332, 2009.
39. Lamarche MG, Wanner BL, Crépin S, Harel J. The phosphate regulon and bacterial virulence: a regulatory network connecting phosphate homeostasis and pathogenesis. FEMS Microbiol Rev. 32(3): 461-473, 2008.
40. Glattard E, Welters ID, Lavaux T, Muller AH, Laux A, Zhang D, Schmidt AR, Delalande F, Laventie BJ, Dirrig-Grosch S, et al. Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS One. 5(1): e8791, 2010.
41. Williams JP, Thompson JP, Young SP, Gold SJ, McDonald J, Rowbotham DJ, Lambert DG. Nociceptin and urotensin-II concentrations in critically ill patients with sepsis. Br J Anaesth. 100(6): 810-814, 2008.
42. Zaborina O, Lepine F, Xiao G, Valuckaite V, Chen Y, Li T, Ciancio M, Zaborin A, Petrof EO, Turner JR, et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog. 3(3): e35, 2007.
43. Zaborin A, Gerdes S, Holbrook C, Liu DC, Zaborina OY, Alverdy JC. Pseudomonas aeruginosa overrides the virulence inducing effect of opioids when it senses an abundance of phosphate. PLoS One. 7(4): e34883, 2012.
44. Köhler T, Buckling A, van Delden C. Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc Natl Acad Sci U S A. 106(15): 6339-6344, 2009.
45. Wang M, Schaefer AL, Dandekar AA, Greenberg EP. Quorum sensing and policing of Pseudomonas aeruginosa social cheaters. Proc Natl Acad Sci U S A. 112(7): 2187-2191, 2015.
46. Wu L, Estrada O, Zaborina O, Bains M, Shen L, Kohler JE, Patel N, MuschMW, Chang EB, Fu YX, et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science. 309((5735)): 774-777, 2005.
47. Zaborina O, Lepine F, Xiao G, Valuckaite V, Chen Y, Li T, Ciancio M, Zaborin A, Petroff E, Turner IR, et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog. 3(3): e35, 2007.
48. Kohler JE, Zaborina O, Wu L, Wang Y, Bethel C, Chen Y, Shapiro J, Turner JR, Alverdy JC. Components of intestinal epithelial hypoxia activate the virulence circuitry of Pseudomonas. Am J Physiol Gastrointest Liver Physiol. 288(5): G1048-G1054, 2005.
49. Patel NJ, Zaborina O, Wu L, Wang Y, Wolfgeher DJ, Valuckaite V, Ciancio MJ, Kohler JE, Shevchenko O, Colgan SP, et al. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol. 292(1): G134-G142, 2007.
50. Morowitz MJ, Babrowski T, Carlisle EM, Olivas A, Romanowski KS, Seal JB, Liu DC, Alverdy JC. The human microbiome and surgical disease. Ann Surg. 253(6): 1094-1101, 2011.
51. Stecher B, Chaffron S, Käppeli R, Hapfelmeier S, Freedrich S, Weber TC, Kirundi J, Suar M, McCoy KD, von Mering C, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 6(1): e1000711, 2010.
52. Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W, Raffatellu M. The cytokine IL-22 promotes pathogen colonization by supressening related commensal bacteria. Immunity. 40: 262-273, 2014.
53. Hendrickson BA, Guo J, Laughlin R, Chen Y, Alverdy JC. Increased type 1 fimbrial expression among commensal Escherichia coli isolates in the murine cecum following catabolic stress. Infect Immun. 67(2): 745-753, 1999.
54. Ayres JS, Trinidad NJ, Vance RE. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med. 18(5): 799-806, 2012.
55. Kofoed EM, Vance RE. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature. 477(7366): 592-595, 2011.
56. Zaborina O, Zaborin A, Romanowski K, Babrowski T, Alverdy J. Host stress and virulence expression in intestinal pathogens: development of therapeutic strategies using mice and C elegans. Curr Pharm Des. 17(13): 1254-1260, 2011.
57. Brown SP, Cornforth DM, Mideo N. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol. 20(7): 336-342, 2012.
58. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 108(Suppl 1): 4554-4561, 2011.
59. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 455(7214): 804-807, 2008.
60. Zoumpopoulou G, Tsakalidou E, Dewulf J, Pot B, Grangette C. Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int J Food Microbiol. 131(1): 40-51, 2009.
61. Bahrami B, Macfarlane S, Macfarlane GT. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. J Appl Microbiol. 110(1): 353-363, 2011.
62. Franklin BS, Latz E. For guts sake: NLRC4 Inflammasomes distinguish friend from foe. Nat Immunol. 13(5): 429-431, 2012.
63. Franchi L, Kamada N, Nakamura Y, Burberry A, Kuffa P, Suzuki S, Shaw MH, Kim YG, Núñez G. NLRC4-driven production of IL-1b discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol. 13(5): 449-456, 2012.
64. Srinivasan N. Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites. Innate Immun. 16(6): 391-404, 2010.
65. Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY, OConnor W Jr, Rongvaux A, Van Rooijen N, Haberman AM, et al. Control of TH17 cells occurs in the small intestine. Nature. 475(7357): 514-518, 2011.
66. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 203(10): 2271-2279, 2006.
67. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med. 207(6): 1293-1305, 2010.
68. Kolls JK, McCray PB Jr, Chan YR. Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Immunol. 8(11): 829-835, 2008.
69. Gama JA, Abby SS, Vieira-Silva S, Dionisio F, Rocha EP. Immune subversion and quorum-sensing shape the variation in infectious dose among bacterial pathogens. PLoS pathogens. 8(2): e1002503, 2012.
70. Kendall MM, Sperandio V. Quorum sensing by enteric pathogens. Curr Opin Gastroenterol. 23(1): 10-15, 2007.
71. Antunes LC, Ferreira RB. Intercellular communication in bacteria. Crit Rev Microbiol. 35(2): 69-80, 2009.
72. Antunes LC, Ferreira RB, Buckner MM, Finlay BB. Quorum sensing in bacterial virulence. Microbiology. 156: 2271-2282, 2010.
73. Roux A, Payne SM, Gilmore MS. Microbial telesensing: probing the environment for friends, foes, and food. Cell Host Microbe. 6(2): 115-124, 2009.
74. Smalley NE, An D, Parsek MR, Chandler JR, Dandekar AA. Quorum sensing protects Pseudomonas aeruginosa against cheating by other species in a laboratory co-culture model. J Bacteriol. 197(19): 3154-3159, 2015.
75. Dandekar AA, Chugani S, Greenberg EP. Bacterial quorum sensing and metabolic incentives to cooperate. Science. 338(6104): 264-266, 2012.
76. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 9(4): 228-236, 2009.
77. Khuntayaporn P, Montakantikul P, Mootsikapun P, Thamlikitkul V, Chomnawang MT. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand. Ann Clin Microbiol Antimicrob. 11(1): 25, 2012.
78. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 21(3): 538-582, 2008.
79. Kravchenko VV, Kaufmann GF, Mathison JC, Scott DA, Katz AZ, Grauer DC, Lehmann M, Meijler MM, Janda KD, Ulevitch RJ. Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule. Science. 321(5886): 259-263, 2008.
80. Wu F, Menn DJ, Wang X. Quorum-sensing crosstalk-driven synthetic circuits: from unimodality to trimodality. Chem Biol. 21(12): 1629-1638, 2014.
81. Boyle KE, Monaco H, van Ditmarsch D, Deforet M, Xavier JB. Integration of Metabolic and Quorum Sensing Signals Governing the Decision to Cooperate in a Bacterial Social Trait. PLoS Comput Biol. 11(5): e1004279, 2015.
82. Antunes LC, McDonald JA, Schroeter K, Carlucci C, Ferreira RB, Wang M, Yurist-Doutsch S, Hira G, Jacobson K, Davies J, et al. Antivirulence activity of the human gut metabolome. MBio. 5(4): e01183-e01214, 2014.
83. Gallie J, Libby E, Bertels F, Remigi P, Jendresen CB, Ferguson GC, Desprat N, Buffing MF, Sauer U, Beaumont HJ, et al. Bistability in a metabolic network underpins the de novo evolution of colony switching in Pseudomonas fluorescens. PLoS Biol. 13(3): e1002109, 2015.
84. Morandi B, Agazzi A, DAgostino A, Antonini F, Costa G, Sabatini F, Ferlazzo G, Melioli G A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. Immunol Lett. 138(1): 86-91, 2011.
85. Alverdy J, Holbrook C, Rocha F, Seiden L, Wu RL, Musch M, Chang E, Ohman D, Suh S. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg. 232(4): 480-489, 2000.
86. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol. 4(12): 953-964, 2004.
87. Petrof EO, Dhaliwal R, Manzanares W, Johnstone J, Cook D, Heyland DK. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med. 40(12): 3290-3302, 2012.
88. Morrow LE, Gogineni V, Malesker MA. Probiotics in the intensive care unit. Nutr Clin Pract. 27(2): 235-241, 2012.
89. Jacobi CA, Schulz C, Malfertheiner P. Treating critically ill patients with probiotics: beneficial or dangerous?. Gut Pathog. 3(1): 2, 2011.
90. Morrow LE, Gogineni V, Malesker MA. Probiotic, prebiotic, and synbiotic use in critically ill patients. Curr Opin Crit Care. 18(2): 186-191, 2012.
91. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 3(9): 541-548, 2007.
92. Zaborin A, Defazio JR, Kade M, Kaiser BL, Belogortseva N, Camp DG 2nd, Smith RD, Adkins JN, Kim SM, Alverdy A, et al. Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens. Antimicrob Agents Chemother. 58(2): 966-977, 2014.
93. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, Gordon JI. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A. 108(15): 6252-6257, 2011.
94. Mellbye B, Schuster M. The sociomicrobiology of antivirulence drug resistance: a proof of concept. Mbio. 2(5): e00131-11, 2011.
95. Baquero F, Coque TM, de la Cruz F. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother. 55(8): 3649-3660, 2011.
96. Little AE, Robinson CJ, Peterson SB, Raffa KF, Handelsman J. Rules of engagement: interspecies interactions that regulate microbial communities. Annu Rev Microbiol. 62: 375-401, 2008.
97. Vayssier-Taussat M, Albina E, Citti C, Cosson JF, Jacques MA, Lebrun MH, Le Loir Y, Ogliastro M, Petit MA, Roumagnac P, Candresse T. Shifting the paradigm from pathogens to pathobiome: new concepts in the light of metaomics. Front Cell Infect Microbiol. 4: 29, 2014.
98. Seal JB, Alverdy JC, Zaborina O, An G. Agent-based dynamic knowledge representation of Pseudomonas aeruginosa virulence activation in the stressed gut: towards characterizing host-pathogen interactions in gut-derived sepsis. Theor Biol Med Model. 8: 33, 2011.